Glucose Variability With DPP-4 Inhibition
Glucose Variability With DPP-4 Inhibition
Glucose Variability With DPP-4 Inhibition
Patients with Type 2 Diabetes, age 35-75y., will be included in this double blind randomized placebo controlled study.
The sample size of 50 patients completing the 30 day study period is based on statistical input from Merck Research Laboratories, Rahway NJ.
Inclusion Criteria:
Exclusion Criteria: